[go: up one dir, main page]

MA22076A1 - Nouveaux derives de n-(4-piperidinyl) (dihydrobenzofuranne ou dihydro-2h-benzopyranne) carboxamides et intermediaires et procede pour leur preparation - Google Patents

Nouveaux derives de n-(4-piperidinyl) (dihydrobenzofuranne ou dihydro-2h-benzopyranne) carboxamides et intermediaires et procede pour leur preparation

Info

Publication number
MA22076A1
MA22076A1 MA22349A MA22349A MA22076A1 MA 22076 A1 MA22076 A1 MA 22076A1 MA 22349 A MA22349 A MA 22349A MA 22349 A MA22349 A MA 22349A MA 22076 A1 MA22076 A1 MA 22076A1
Authority
MA
Morocco
Prior art keywords
aryl
alkyl
alk
cycloalkyl
piperidinyl
Prior art date
Application number
MA22349A
Other languages
English (en)
Inventor
Georges Henri Paul Van Daele
Jean-Paul Rene Marie Bosmans
Michel Anna Jozef De Cleyn
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA22076A1 publication Critical patent/MA22076A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
MA22349A 1990-03-06 1991-03-06 Nouveaux derives de n-(4-piperidinyl) (dihydrobenzofuranne ou dihydro-2h-benzopyranne) carboxamides et intermediaires et procede pour leur preparation MA22076A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909005014A GB9005014D0 (en) 1990-03-06 1990-03-06 N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives

Publications (1)

Publication Number Publication Date
MA22076A1 true MA22076A1 (fr) 1991-10-01

Family

ID=10672103

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22349A MA22076A1 (fr) 1990-03-06 1991-03-06 Nouveaux derives de n-(4-piperidinyl) (dihydrobenzofuranne ou dihydro-2h-benzopyranne) carboxamides et intermediaires et procede pour leur preparation

Country Status (38)

Country Link
US (2) US5185335A (fr)
EP (1) EP0445862B1 (fr)
JP (1) JP2601566B2 (fr)
KR (1) KR0177521B1 (fr)
CN (1) CN1038936C (fr)
AT (1) ATE191912T1 (fr)
AU (1) AU636012B2 (fr)
BG (1) BG60381B1 (fr)
CA (1) CA2037575C (fr)
CY (1) CY2235B1 (fr)
CZ (1) CZ286617B6 (fr)
DE (1) DE69132119T2 (fr)
DK (1) DK0445862T3 (fr)
ES (1) ES2147175T3 (fr)
FI (1) FI101622B1 (fr)
GB (1) GB9005014D0 (fr)
GR (1) GR3033461T3 (fr)
HR (1) HRP930483B1 (fr)
HU (2) HU221627B1 (fr)
IE (1) IE910710A1 (fr)
IL (1) IL97018A (fr)
LT (1) LT3708B (fr)
LV (1) LV10085B (fr)
MA (1) MA22076A1 (fr)
MY (1) MY108831A (fr)
NO (1) NO177424C (fr)
NZ (1) NZ237189A (fr)
PL (6) PL168693B1 (fr)
PT (1) PT96937B (fr)
RU (1) RU2070884C1 (fr)
SG (1) SG47482A1 (fr)
SI (1) SI9110396B (fr)
SK (2) SK282407B6 (fr)
TN (1) TNSN91010A1 (fr)
UA (1) UA25969A1 (fr)
YU (1) YU48854B (fr)
ZA (1) ZA911611B (fr)
ZW (1) ZW2391A1 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674849B1 (fr) * 1991-04-02 1994-12-23 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
HUT70154A (en) * 1991-09-12 1995-09-28 Smithkline Beecham Plc 5-ht4 receptor antagonists and pharmaceutical compositions containing them
JPH07503480A (ja) * 1992-02-06 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４拮抗薬としてのベンゾピラン，ベンゾチオピランおよびベンゾフラン誘導体
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
GB9219163D0 (en) * 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
JPH08502273A (ja) * 1992-10-13 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド
TW294595B (fr) * 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
JPH0820586A (ja) 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
AU702846B2 (en) * 1994-09-27 1999-03-04 Janssen Pharmaceutica N.V. Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives
ES2141383T3 (es) * 1994-09-27 2000-03-16 Janssen Pharmaceutica Nv Derivados de benzoatos biciclicos de piperidinilo sustituido en n.
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
TWI242004B (en) 1998-04-28 2005-10-21 Dainippon Pharmaceutical Co 1-(1-substituted-4-piperidinyl)methyl-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
EP1077973A2 (fr) * 1998-05-14 2001-02-28 Egis Gyogyszergyar Rt. Derives de benzofuranne, composition pharmaceutique renfermant ces derives et procede de preparation du principe actif
ES2283132T3 (es) 1998-09-10 2007-10-16 F. Hoffmann-La Roche Ag Dihidrobenzodiaxin carboxamida y derivados de cetona como antagonistas receptores de 5-ht4.
CA2352278A1 (fr) * 1998-11-23 2000-06-02 Janssen Pharmaceutica, N.V. Utilisation de prucalopride dans la production d'un medicament de traitement de la dyspepsie
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
KR100702889B1 (ko) * 2002-03-28 2007-04-04 다나베 세이야꾸 가부시키가이샤 벤조푸란 유도체
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
DE10349113A1 (de) * 2003-10-17 2005-05-12 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aminocrotonylverbindungen
CA2557645C (fr) * 2004-02-27 2013-09-24 Vertex Pharmaceuticals Incorporated Inhibiteurs de la caspase et leurs utilisations
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
SI2007756T1 (sl) * 2006-04-07 2015-11-30 Vertex Pharmaceuticals Incorporated Modulatorji prenašalcev z atp-vezavno kaseto
CN102477002B (zh) * 2010-11-26 2015-04-15 苏州凯达生物医药技术有限公司 3-氨基-2,2-双甲基丙酰胺的制备方法
ES2587304T3 (es) 2011-02-25 2016-10-21 Yuhan Corporation Derivados de diaminopirimidina y procedimientos para la preparación de los mismos
GB201103397D0 (fr) * 2011-02-28 2011-04-13 Shire Movetis N V
KR101256908B1 (ko) * 2011-04-28 2013-04-23 (주)에이치비메디컬스 주름제거용 충전체
CN102295594B (zh) * 2011-07-12 2016-01-20 上海医药工业研究院 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
EP2744493A1 (fr) 2011-08-18 2014-06-25 Shire AG Combinaisons d'un agoniste de récepteur 5-ht4 et d'un inhibiteur de pde4 pour utilisation en thérapie
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
EP3413891B1 (fr) * 2016-02-11 2024-01-03 Symed Labs Limited Procédés pour la préparation de succinate de prucalopride très pur
CN110963999B (zh) * 2019-11-27 2021-05-11 广东东阳光药业有限公司 2,3-二氢苯并呋喃酰胺衍生物及其用途
JP7753254B2 (ja) * 2020-05-04 2025-10-14 武田薬品工業株式会社 内腔で作用するｎ－（ピペリジン－４－イル）ベンズアミド誘導体

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2396757A2 (fr) * 1977-07-08 1979-02-02 Ile De France Nouveaux 2,3-alkylene bis (oxy) benzamides substitues, leurs derives et leurs procedes de preparation
FR2493848B2 (fr) * 1980-11-07 1986-05-16 Delalande Sa Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
EP0069481A1 (fr) * 1981-06-17 1983-01-12 Beecham Group Plc Azabicycloalkylbenzamides, leur procédé de préparation et les compositions pharmaceutiques les contenant
EP0068700A1 (fr) * 1981-06-29 1983-01-05 Beecham Group Plc Azabicycloalkylbenzamides, leur procédé de préparation et les compositions pharmaceutiques les contenant
CA1183847A (fr) 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide; derives
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
CA1223873A (fr) * 1982-04-14 1987-07-07 Francis D. King Composes pharmaceutiques
EP0108986A1 (fr) * 1982-11-02 1984-05-23 Hokuriku Pharmaceutical Co.,Ltd Flavones-8-carboxamides N-substituées
EP0135545A1 (fr) * 1983-02-19 1985-04-03 Beecham Group Plc Derives anylides et benzamides d'azabicycloalkyle
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
CA1297877C (fr) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides utilises comme agents antiemetiques ou antipsychotiques
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
FR2593504B1 (fr) 1986-01-30 1988-12-09 Ile De France Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
NZ225152A (en) 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
US4906643A (en) * 1987-07-17 1990-03-06 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents
US5130312A (en) * 1987-07-17 1992-07-14 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides
GB8718346D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa Substituted benzamides
ZA886585B (en) * 1987-09-08 1990-05-30 Lilly Co Eli Specific 5-ht,antagonists
US5041454A (en) * 1987-09-25 1991-08-20 Janssen Pharmaceutica N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
CA1317940C (fr) 1987-09-25 1993-05-18 Georges H. P. Van Daele N-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides a substituant
US4975439A (en) * 1987-09-25 1990-12-04 Janssen Pharmaceutical N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US4863921A (en) * 1988-04-27 1989-09-05 Rorer Pharmaceutical Corporation Dibenzofurancarboxamides and their pharmaceutical compositions and methods
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Also Published As

Publication number Publication date
FI911096A0 (fi) 1991-03-05
EP0445862B1 (fr) 2000-04-19
FI911096A7 (fi) 1991-09-07
NO910863D0 (no) 1991-03-05
ZA911611B (en) 1992-11-25
DE69132119T2 (de) 2000-12-21
PL168356B1 (pl) 1996-02-29
SI9110396A (en) 1997-12-31
PL168693B1 (pl) 1996-03-29
CS46091A3 (en) 1991-10-15
CY2235B1 (en) 2003-07-04
EP0445862A3 (en) 1992-05-20
CN1054598A (zh) 1991-09-18
TNSN91010A1 (fr) 1992-10-25
RU2070884C1 (ru) 1996-12-27
PL168384B1 (en) 1996-02-29
JPH04211685A (ja) 1992-08-03
NO910863L (no) 1991-09-09
SI9110396B (sl) 2000-06-30
PT96937B (pt) 1998-07-31
IL97018A (en) 1995-11-27
UA25969A1 (uk) 1999-02-26
FI101622B (fi) 1998-07-31
LV10085B (en) 1995-02-20
PL168686B1 (pl) 1996-03-29
PL169238B1 (pl) 1996-06-28
EP0445862A2 (fr) 1991-09-11
LTIP846A (en) 1995-02-27
PT96937A (pt) 1991-10-31
NO177424B (no) 1995-06-06
NZ237189A (en) 1992-11-25
SK282406B6 (sk) 2002-01-07
BG93979A (bg) 1993-12-24
ZW2391A1 (en) 1992-09-07
CA2037575C (fr) 2003-09-16
PL289323A1 (en) 1992-03-09
GR3033461T3 (en) 2000-09-29
HRP930483A2 (en) 1995-12-31
SK282407B6 (sk) 2002-01-07
YU39691A (sh) 1994-06-10
IE910710A1 (en) 1991-09-11
US5262418A (en) 1993-11-16
GB9005014D0 (en) 1990-05-02
YU48854B (sh) 2002-06-19
HRP930483B1 (en) 2001-04-30
DE69132119D1 (de) 2000-05-25
KR0177521B1 (ko) 1999-03-20
LV10085A (lv) 1994-05-10
CA2037575A1 (fr) 1991-09-07
FI101622B1 (fi) 1998-07-31
JP2601566B2 (ja) 1997-04-16
PL168811B1 (pl) 1996-04-30
LT3708B (en) 1996-02-26
DK0445862T3 (da) 2000-09-04
CN1038936C (zh) 1998-07-01
MY108831A (en) 1996-11-30
HK1010727A1 (en) 1999-06-25
NO177424C (no) 1995-09-13
BG60381B1 (bg) 1995-01-31
AU636012B2 (en) 1993-04-08
HU211350A9 (en) 1995-11-28
AU7207991A (en) 1991-09-12
ES2147175T3 (es) 2000-09-01
US5185335A (en) 1993-02-09
SG47482A1 (en) 1998-04-17
HUT60733A (en) 1992-10-28
KR910016744A (ko) 1991-11-05
HU910706D0 (en) 1991-09-30
ATE191912T1 (de) 2000-05-15
CZ286617B6 (cs) 2000-05-17
HU221627B1 (hu) 2002-12-28
IL97018A0 (en) 1992-03-29

Similar Documents

Publication Publication Date Title
MA22076A1 (fr) Nouveaux derives de n-(4-piperidinyl) (dihydrobenzofuranne ou dihydro-2h-benzopyranne) carboxamides et intermediaires et procede pour leur preparation
NZ507119A (en) 1-[(4-Piperidinyl)methyl]-4-piperidine derivatives useful for treating gastrointestinal disorders
ATE127456T1 (de) Pyridazinon derivate und verfahren zur deren herstellung.
CO4520230A1 (es) Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptores
NZ333513A (en) 1,4-di-substituted piperidines and medicaments useful as muscarinic antagonists
MY133108A (en) Muscarinic antagonists
ATE72431T1 (de) 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
ATE285403T1 (de) Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen
ATE182325T1 (de) Tricyclische amidverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE42747T1 (de) N-(2-(tetrahydro-3,5-dioxo-1h-pyrrolizin-7a(5h) yl)ethyl>aminderivate.
HRP20100010T1 (hr) Derivati 1h-indol-piridinkarboksamida i 1h-indol-piperidinkarboksamida i njihova uporaba kao izazivača tirozin hidroksilaze
MY101878A (en) 1,3,4-thiadiazole